Concepedia

Masateru Ohta

MO

Statistics

Publications

39

Citations

1.4K

H-Index

20

Active since

1973

Affiliations

Chugai Pharma (United States)(Current)

RIKEN Center for Computational Science

Yokohama City University

Niigata University

Tokai University

Masateru Ohta is an author at Chugai Pharma (United States) specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

1973–2023

39

Publications

39

Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy

Masateru Ohta, Yutaka Tokuda, Yasuhiro Suzuki et al. · Nuclear Medicine Communications · 2001 · 177 citations

, , +12

Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models

Yoriko Yamashita‐Kashima, Shigeyuki Iijima, Keigo Yorozu et al. · Clinical Cancer Research · 2011 · 176 citations · Full text

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

Yutaka Tokuda, Toru Watanabe, Yasushi Omuro et al. · British Journal of Cancer · 1999 · 113 citations · Full text

kGCN: a graph-based deep learning framework for chemical structures

Ryosuke Kojima, Shoichi Ishida, Masateru Ohta et al. · Journal of Cheminformatics · 2020 · 98 citations · Full text

Structure and ionic conductivity of MLaNb2O7 (M K, Na, Li, H)

Mineo Sato, J. Abo, Tetsuro Jin et al. · Journal of Alloys and Compounds · 1993 · 81 citations

1–5 of 39